(ATHA) – Business Wire
-
Ric Kayne Suspends Campaign to Elect Himself and George Bickerstaff to Athira Pharma Board of Directors
-
Ric Kayne Issues Letter to Athira Shareholders Highlighting Need for Immediate Change to Athira Board
-
Leading Proxy Advisory Firm ISS Recommends Athira Shareholders “Withhold” Support From Incumbent Directors Joseph Edelman and John Fluke
-
Ric Kayne Identifies Highly Qualified CEO Candidate for Athira
-
Ric Kayne Issues Letter to Athira Shareholders Highlighting Why Immediate Board Change Is Required
-
Ric Kayne Publishes Investor Presentation Highlighting Urgent Need for Changes to Athira’s Board of Directors
-
Ric Kayne Files Definitive Proxy Materials for Athira’s 2022 Annual Meeting
-
Ric Kayne and Affiliates Confirm Nomination of Two Highly Qualified Candidates for Election to Athira Pharma’s Board of Directors
Back to ATHA Stock Lookup
